Aurobindo Pharma has received 9 Form 483 observations from USFDA, for its Unit IV injectable facility. Unit IV is situated inΒ Pashamailaram near Hyderabad, where it...
Laurus Labs has received Form 483 with zero observations for Unit 2 (the formulations unit). The United States Food and Drug Administration (USFDA) has successfully...
Natco Pharma has filed an abbreviated new drug application (ANDA) for Sofosbuvir Tablets, 400mg, with the United States Food and Drug Administration (USFDA). The company...
Zydus Cadila, has received final approval from US health regulator to marketΒ Dexmedetomidine Hydrochloride injection. The company in a regulatory filing stated that, the approval is...
Granules India has received EIR from US Food and Drug Administration (USFDA), for Chantilly unit. USFDA has issued establishment inspection report (EIR) for Granules Pharmaceuticals,...
Lupin has received final approval from the US health regulator, for itsΒ Oseltamivir Phosphate. In a BSE filing the company stated that, it has received final...
Biocon has received 6 observations from the US health regulator, after it had inspected its Malaysia manufacturing facility. The company in a regulatory filing stated,...
Natco Pharma’s,Β Mekaguda facility near Hyderabad, has received zero observations from the US health regulator. The company in its filing stated, “….announce successful completion of regulatory...
Strides Shasun’s wholly owned subsidiary Strides Pharma Global Pte. Ltd has got green signalΒ from the US Food and Drug Administration,Β for Tenofovir Disoproxil Fumarate tablets, 300...
Lupin has received US health regulator’s approval for generic Tamiflu Capsules. The company stated that, it has received final approval for its Oseltamivir Phosphate Capsules...